Is CVAC or XYLD a better dividend investment in 2026?

CVAC currently yields 42.92% with a 5% 5-year dividend growth rate. XYLD yields 10.98% with 0.5% growth. The better choice depends on your goal: CVAC offers higher current income.

What is the dividend yield difference between CVAC and XYLD?

CVAC has a forward dividend yield of 42.92% ($2.00/share annually). XYLD yields 10.98% ($4.30/share annually). The yield gap is 31.94 percentage points.

Home › Compare › CVAC vs XYLD

CVAC vs XYLD: Dividend Comparison 2026

CVAC yields 42.92% · XYLD yields 10.98%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CVAC wins by $246.2K in total portfolio value

INVESTMENT

TIME HORIZON10 years

CVAC

● Live price

42.92%

Share price

$4.66

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$271.5K

Annual income

$48,622.47

Full CVAC calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

10.98%

Share price

$39.13

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.3K

Annual income

$3,219.02

Full XYLD calculator →

Portfolio growth — CVAC vs XYLD

📍 CVAC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CVAC	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CVAC + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CVAC pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CVAC

Annual income on $10K today (after 15% tax)

$3,648.07/yr

After 10yr DRIP, annual income (after tax)

$41,329.10/yr

XYLD

Annual income on $10K today (after 15% tax)

$933.63/yr

After 10yr DRIP, annual income (after tax)

$2,736.17/yr

At 15% tax rate, CVAC beats the other by $38,592.93/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CVAC + XYLD for your $10,000?

CVAC: 50%XYLD: 50%

100% XYLD50/50100% CVAC

Portfolio after 10yr

$148.4K

Annual income

$25,920.74/yr

Blended yield

17.47%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on CVAC right now

CVAC

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$21.00

+350.6% upside vs current

Range: $5.00 — $37.00

Altman Z

1.7

Piotroski

3/9

XYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CVAC buys

XYLD buys

No recent congressional trades found for CVAC or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCVACXYLD

Forward yield	42.92% ✓	10.98%
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$271.5K ✓	$25.3K
Annual income after 10y	$48,622.47 ✓	$3,219.02
Total dividends collected	$208.4K ✓	$19.6K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: CVAC vs XYLD ($10,000, DRIP)

Year	CVAC Portfolio	CVAC Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$14,992	$4,291.85	$10,818	$1,098.39	+$4.2K → CVAC
2	$22,055	$6,013.34	$11,738	$1,222.51	+$10.3K → CVAC
3	$31,866	$8,267.53	$12,774	$1,364.64	+$19.1K → CVAC
4	$45,261	$11,164.00	$13,944	$1,527.86	+$31.3K → CVAC
5	$63,248	$14,819.35	$15,270	$1,715.87	+$48.0K → CVAC
6	$87,030	$19,354.11	$16,775	$1,933.09	+$70.3K → CVAC
7	$118,011	$24,889.07	$18,490	$2,184.87	+$99.5K → CVAC
8	$157,813	$31,541.28	$20,450	$2,477.63	+$137.4K → CVAC
9	$208,280	$39,419.96	$22,697	$2,819.19	+$185.6K → CVAC
10	$271,482	$48,622.47	$25,280	$3,219.02	+$246.2K → CVAC

CVAC vs XYLD: Complete Analysis 2026

CVAC — Stock

CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for rabies virus glycoprotein; and CVSQIV, which is in Phase 1 clinical trial against influenza, as well as vaccine for lassa fever, yellow fever, respiratiory syncytial virus, rotavirus, malaria, and universal influenza. The company also develops RNA-based cancer immunotherapies, including CV8102, which is in Phase 1 clinical trial for treating cutaneous melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck. The company was founded in 2000 and is headquartered in Tübingen, Germany.

Full CVAC Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this CVAC vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CVAC vs SCHD CVAC vs JEPI CVAC vs O CVAC vs KO CVAC vs MAIN CVAC vs QYLD CVAC vs JEPQ CVAC vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.